Literature DB >> 26852068

A case of aquagenic urticaria successfully treated with omalizumab.

Andrew Rorie1, Selina Gierer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26852068     DOI： 10.1016/j.jaip.2015.12.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Clinical impact of omalizumab in refractory chronic urticaria: One centre experience.

Authors:  Diana Deleanu; Irena Nedelea; Carina Petricau; Poliana Leru; Dinu Dumitrascu; Adriana Muntean
Journal:  Exp Ther Med       Date:  2019-10-24       Impact factor: 2.447

2.  Evidence for histamine release in chronic inducible urticaria - A systematic review.

Authors:  Kanokvalai Kulthanan; Martin K Church; Eva Maria Grekowitz; Tomasz Hawro; Lea Alice Kiefer; Kanyalak Munprom; Yanisorn Nanchaipruek; Chuda Rujitharanawong; Dorothea Terhorst-Molawi; Marcus Maurer
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.